Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORION: JX10 in Acute Ischemic Stroke
NCT06990867Phase 3Recruiting
- Sponsor
- CORXEL Pharmaceuticals
- Start
- May 2025
- Primary completion
- Oct 2029
- Modality
- Small Molecules
- Countries
- 21
01
Overview
A Phase 3 trial of JX10 in ischemic stroke, sponsored by CORXEL Pharmaceuticals. Started May 2025; status: recruiting.
02
Drugs
JX10
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06990867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06990867.